Update Schwangerschaftsrhinitis

U. Friebe-Hoffmann; J. Lindemann

doi:10.1055/a-0589-3218

Laryngo-Rhino-Otologie, Inhaltsverzeichnis

Laryngorhinootologie 2018; 97(07): 457-464
DOI: 10.1055/a-0589-3218

Übersicht

Update Schwangerschaftsrhinitis

Pregnancy Rhinitis – an Update

U. Friebe-Hoffmann

¹Klinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Ulm, Ulm

,

J. Lindemann

²Klinik für Hals-Nasen-Ohrenheilkunde und Kopf-Hals-Chirurgie, Universitätsklinikum Ulm, Ulm

› Institutsangaben

Abstract

Zusammenfassung

Als sog. Schwangerschaftsrhinitis (SSR) wird eine mehrwöchige, schwangerschaftsbegleitende nasale Obstruktion bezeichnet, die sich durch eine Schwellung der Mukosa sowie vermehrte Sekretion ohne Hinweis auf eine Entzündung, Infektion, Allergie oder Raumforderung auszeichnet und deren Symptome nach der Geburt rasch wieder verschwinden. Die SSR zählt zu den endokrinen nasalen Hyperreaktivitäten. Etwa ein Viertel aller Schwangeren ist von diesem Krankheitsbild betroffen, das zu jedem Zeitpunkt der Schwangerschaft auftreten kann. Pathophysiologisch werden vor allem hormonelle Einflüsse diskutiert, Rauchen sowie eine vorbestehende Hausstaubmilbenallergie gelten als Risikofaktoren. Nachfolgend stellen wir ein stufentherapeutisches Konzept für die Behandlung der SSR vor und diskutieren die aktuelle Literatur.

Abstract

Pregnancy rhinitis (PR), a common condition in pregnant women, is defined as long-lasting nasal congestion due to mucosal swelling and increased secretion without any signs of infection, allergy or tumor, starting at any time during pregnancy and disappearing within 2 weeks of delivery. Smoking and a sensitization to house dust mites are known risk factors. While a definitive pathophysiological concept for PR does not exist, hormonal influences are discussed. We present a stepwise therapeutic strategy for PR and an overview to the latest literature.

Schlüsselwörter

Schwangerschaft - Rhinitis - Rinopathia gravidarum - Nasale Hyperreaktivität

Key words

Pregnancy - rhinitis - nasal hyperreactivity - rhinopathia gravidarum

Volltext

Referenzen

Literatur
1 MacKenzie J. The physiological and pathophysiological relations between the nose and the sexual apparatus of man. Alienist Neurol 1898; 19: 219-239
2 Bachert C. Die chronisch verstopfte Nase – Zur Klassifikation der nasalen Hyperreaktivität. Dtsch Arztebl 1996; 93: A1034-1038
3 Caparroz FA, Gregorio LL, Bongiovanni G. et al. Rhinitis and pregnancy: literature review. Braz J Otorhinolaryngol 2016; 82: 105-111
4 Orban N, Maughan E, Bleach N. Pregnancy-induced rhinitis. Rhinology 2013; 51: 111-1119
5 Ellegård E, Hellgren M, Torén K. et al. The incidence of pregnancy rhinitis. Gynecol Obstet Invest 2000; 49: 98-101
6 Ellegård E, Karlsson G. Nasal congestion during pregnancy. Clin Otolaryngol Allied Sci 1999; 24: 307-311
7 Ellegård EK. The etiology and management of pregnancy rhinitis. Am J Respir Med Drugs Devices Interv 2003; 2: 469-475
8 Ellegård EK. Pregnancy rhinitis. Immunol Allergy Clin North Am 2006; 26: 119-135
9 Franklin KA, Holmgren PA, Jönsson F. et al. Snoring, pregnancy-induced hypertension, and growth retardation of the fetus. Chest 2000; 117: 137-141
10 Juniper EF. Measuring health-related quality of life in rhinitis. J Allergy Clin Immunol 1997; 99: S742-S749
11 Gilbey P, McGruthers L, Morency A-M. et al. Rhinosinusitis-related quality of life during pregnancy. Am J Rhinol Allergy 2012; 26: 283-286
12 Ayrım A, Keskin EA, Ozol D. et al. Influence of self-reported snoring and witnessed sleep apnea on gestational hypertension and fetal outcome in pregnancy. Arch Gynecol Obstet 2011; 283: 195-199
13 Sahin FK, Koken G, Cosar E. et al. Obstructive sleep apnea in pregnancy and fetal outcome. Int. J. Gynaecol. Obstet. Off Organ Int Fed Gynaecol Obstet 2008; 100: 141-146
14 Wolff H, Wolf S, Grace W. et al. Changes in form and function of mucous membranes occurring as part of protective reaction patterns in man during periods of life stress and emotional conflict. Trans Assoc Am Physicians 1948; 61: 313-334
15 Holmes T, Goodell H, Wolf S. et al. The relation of nasal to sexual function. Nose Exp. Study React. Nose Hum. Subj. Varying Life Exp.. Springfield: III Charles C Thomas Publisher; 1950: 89-100
16 Philpott CM, Conboy P, Al-Azzawi F. et al. Nasal physiological changes during pregnancy. Clin Otolaryngol Allied Sci 2004; 29: 343-351
17 Demir UL, Demir BC, Oztosun E. et al. The effects of pregnancy on nasal physiology. Int Forum Allergy Rhinol 2015; 5: 162-166
18 Mortimer H, Wright RP, Collip JB. The Effect of the Administration of OEstrogenic Hormones on the Nasal Mucosa of the Monkey (Macaca Mulatta). Can Med Assoc J 1936; 35: 503-513
19 Taylor M. An experimental study of the influence of the endocrine system on the nasal respiratory mucosa. J Laryngol Otol 1961; 75: 972-977
20 Toppozada H, Michaels L, Toppozada M. et al. The human respiratory nasal mucosa in pregnancy. An electron microscopic and histochemical study. J Laryngol Otol 1982; 96: 613-626
21 Mabry RL. The management of nasal obstruction during pregnancy. Ear Nose Throat J 1983; 62: 28-33
22 Lekas MD. Rhinitis during pregnancy and rhinitis medicamentosa. Otolaryngol. – Head Neck Surg Off J Am Acad Otolaryngol.-Head Neck Surg 1992; 107: 845-848
23 Reynolds SRM, Foster FI. Acetylcholine-equivalent content of the nasal mucosa in rabbits and ctas, before and after administration of estrogen. Am J Physiol.- Leg Content 1940; 131: 422-425
24 Kojda G. Weibliche Sexualhormone, Östrogene. Pharmkologie Toxikol;
25 Strutz J, Arndt O. editors Hormonelle Rhinitis in Kapitel Nase und Nasennebenhöhlen. Prax. HNO-Heilkd. Kopf- Halschirurgie 275 Tabellen. Stuttgart: Thieme; 2001
26 Toppozada H, Toppozada M, El-Ghazzawi I. et al. The human respiratory nasal mucosa in females using contraceptive pills. An ultramicroscopic and histochemical study. J Laryngol Otol 1984; 98: 43-51
27 Mabry RL. Rhinitis of pregnancy. South Med J 1986; 79: 965-971
28 Bende M, Hallgårde M, Sjögren U. et al. Nasal congestion during pregnancy. Clin Otolaryngol Allied Sci 1989; 14: 385-387
29 Ellegård E, Oscarsson J, Bougoussa M. et al. Serum level of placental growth hormone is raised in pregnancy rhinitis. Arch Otolaryngol Head Neck Surg 1998; 124: 439-443
30 Haeggström A, Ostberg B, Stjerna P. et al. Nasal mucosal swelling and reactivity during a menstrual cycle. ORL J Oto-Rhino-Laryngol Its Relat Spec 2000; 62: 39-42
31 Schatz M, Zeiger RS. Diagnosis and management of rhinitis during pregnancy. Allergy Proc Off J Reg State Allergy Soc 1988; 9: 545-554
32 Ellegård E, Karlsson G. IgE-mediated reactions and hyperreactivity in pregnancy rhinitis. Arch. Otolaryngol. Head Neck Surg 1999; 125: 1121-1125
33 Bowser C, Riederer A. [Detection of progesterone receptors in connective tissue cells of the lower nasal turbinates in women]. Laryngorhinootologie 2001; 80: 182-186
34 Skinner DW, Richards SH. Acromegaly--the mucosal changes within the nose and paranasal sinuses. J Laryngol Otol 1988; 102: 1107-1110
35 Zondek B, Bromberg YM. Endocrine allergy; clinical reactions to allergy to endogenous hormones and their treatment. J Obstet Gynaecol Br Emp 1947; 54: 1-19
36 Milosević D, Janosević D, Dergen R. et al. Pathologic conditions associated with drug-induced rhinitis. Srp Arh Celok Lek 2004; 132: 14-17
37 Derkay CS. Eustachian tube and nasal function during pregnancy: a prospective study. Otolaryngol--Head Neck Surg Off J Am Acad Otolaryngol-Head Neck Surg 1988; 99: 558-566
38 Bende M, Gredmark T. Nasal stuffiness during pregnancy. The Laryngoscope 1999; 109: 1108-1110
39 Hellín Meseguer D, Ruiz Cotorruelo V, Ruiz Franco M. The influence of pregnancy on mucociliary nasal transport. An Otorrinolaringológicos Ibero-Am 1994; 21: 595-601
40 Ellegård EK, Karlsson NG. Nasal mucociliary transport in pregnancy. Am J Rhinol 2000; 14: 375-378
41 Eccles R. Nasal airflow in health and disease. Acta Otolaryngol (Stockh) 2000; 120: 580-595
42 Stroud RH, Wright ST, Calhoun KH. Nocturnal nasal congestion and nasal resistance. The Laryngoscope 1999; 109: 1450-1453
43 Rambur B. Pregnancy rhinitis and rhinitis medicamentosa. J Am Acad Nurse Pract 2002; 14: 527-530
44 Turnbull GL, Rundell OH, Rayburn WF. et al. Managing pregnancyrelated nocturnal nasal congestion. The external nasal dilator. J Reprod Med 1996; 41: 897-902
45 Roush SF, Bell L. Obstructive sleep apnea in pregnancy. Am Board Fam Pract 2004; 17: 292-294
46 Graf P, Hallén H. Effect on the nasal mucosa of long-term treatment with oxymetazoline, benzalkonium chloride, and placebo nasal sprays. The Laryngoscope 1996; 106: 605-609
47 Graf P. Rhinitis medicamentosa: a review of causes and treatment. Treat Respir Med 2005; 4: 21-29
48 Schaefer C, Spielmann H, Vetter K. et al. Arzneimittel in Schwangerschaft und Stillzeit. 8., vollständig überarbeitete Aufl. München; Elsevier, Urban; Fischer: 2012
49 Yau W-P, Mitchell AA, Lin KJ. et al. Use of Decongestants During Pregnancy and the Risk of Birth Defects. Am J Epidemiol 2013; 178: 198-208
50 Scadding GK, Lund VJ, Jacques LA. et al. A placebo-controlled study of fluticasone propionate aqueous nasal spray and beclomethasone dipropionate in perennial rhinitis: efficacy in allergic and non-allergic perennial rhinitis. Clin Exp Allergy J Br Soc Allergy Clin Immunol 1995; 25: 737-743
51 Mygind N. Effects of corticosteroid therapy in non-allergic rhinosinusitis. Acta Otolaryngol (Stockh) 1996; 116: 164-166
52 Mabry RL. Evaluation of systemic absorption of intraturbinally injected triamcinolone. Otolaryngol--Head Neck Surg Off J Am Acad Otolaryngol-Head Neck Surg 1981; 89: 268-270
53 van As A, Bronsky E, Grossman J. et al. Dose tolerance study of fluticasone propionate aqueous nasal spray in patients with seasonal allergic rhinitis. Ann Allergy 1991; 67: 156-162
54 Wilson AM, Sims EJ, McFarlane LC. et al. Effects of intranasal corticosteroids on adrenal, bone, and blood markers of systemic activity in allergic rhinitis. J Allergy Clin Immunol 1998; 102: 598-604
55 Allen DB. Systemic effects of intranasal steroids: an endocrinologist’s perspective. J Allergy Clin Immunol 2000; 106: S 179-190
56 Ellegård EK, Hellgren M, Karlsson NG. Fluticasone propionate aqueous nasal spray in pregnancy rhinitis. Clin Otolaryngol Allied Sci 2001; 26: 394-400
57 O’Connell M, Welsh GW. Unbound plasma cortisol in pregnant and Enovid-E treated women as determined by ultrafiltration. J Clin Endocrinol Metab 1969; 29: 563-568
58 Onrust SV, Lamb HM. Mometasone furoate. A review of its intranasal use in allergic rhinitis. Drugs 1998; 56: 725-745
59 Storms WW. Risk-benefit assessment of fluticasone propionate in the treatment of asthma and allergic rhinitis. J Asthma Off J Assoc Care Asthma 1998; 35: 313-336
60 Hallén H, Enerdal J, Graf P. Fluticasone propionate nasal spray is more effective and has a faster onset of action than placebo in treatment of rhinitis medicamentosa. Clin Exp Allergy J Br Soc Allergy Clin Immunol 1997; 27: 552-558